Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
Total Valuation
BioLife Solutions has a market cap or net worth of $1.23B. The enterprise value is $971.62M.
Market Cap$1.23B
Enterprise Value$971.62M
Share Statistics
BioLife Solutions has 47,905,266 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,905,266
Owned by Insiders19.86%
Owned by Institutions0.45%
Financial Efficiency
BioLife Solutions’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.87%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-1.87%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee517.32K
Profits Per Employee-126.94K
Employee Count159
Asset Turnover0.21
Inventory Turnover0.99
Valuation Ratios
The current PE Ratio of BioLife Solutions is ―. BioLife Solutions’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.43
Price to FCF―
Price to Operating Cash Flow78.98
PEG Ratio―
Income Statement
In the last 12 months, BioLife Solutions had revenue of 82.25M and earned -20.18M in profits. Earnings per share was -0.44.
Revenue82.25M
Gross Profit53.67M
Operating Income-7.13M
Pretax Income-11.43M
Net Income-20.18M
EBITDA1.53M
Earnings Per Share (EPS)-0.44
Cash Flow
In the last 12 months, operating cash flow was 15.54M and capital expenditures -4.09M, giving a free cash flow of 11.45M billion.
Operating Cash Flow15.54M
Free Cash Flow11.45M
Free Cash Flow per Share0.24
Dividends & Yields
BioLife Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.00
52-Week Price Change0.32%
50-Day Moving Average22.51
200-Day Moving Average24.32
Relative Strength Index (RSI)63.40
Average Volume (3m)545.02K
Important Dates
BioLife Solutions upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
BioLife Solutions as a current ratio of 4.54, with Debt / Equity ratio of 6.86%
Current Ratio4.54
Quick Ratio3.66
Debt to Market Cap0.01
Net Debt to EBITDA-42.57
Interest Coverage Ratio-9.92
Taxes
In the past 12 months, BioLife Solutions has paid -38.00K in taxes.
Income Tax-38.00K
Effective Tax Rate<0.01
Enterprise Valuation
BioLife Solutions EV to EBITDA ratio is 738.05, with an EV/FCF ratio of 217.27.
EV to Sales13.75
EV to EBITDA738.05
EV to Free Cash Flow217.27
EV to Operating Cash Flow134.11
Balance Sheet
BioLife Solutions has $81.77M in cash and marketable securities with $23.82M in debt, giving a net cash position of -$57.95M billion.
Cash & Marketable Securities$81.77M
Total Debt$23.82M
Net Cash-$57.95M
Net Cash Per Share-$1.21
Tangible Book Value Per Share$2.76
Margins
Gross margin is 82.67%, with operating margin of -8.67%, and net profit margin of -24.54%.
Gross Margin82.67%
Operating Margin-8.67%
Pretax Margin-13.89%
Net Profit Margin-24.54%
EBITDA Margin1.86%
EBIT Margin-8.67%
Analyst Forecast
The average price target for BioLife Solutions is $31.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$31.25
Price Target Upside22.89% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast-18.61%
EPS Growth Forecast92.36%